Articles tagged with Cancer Patients
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A study of 64,034 women found that those with heart problems, chronic lung disease, and diabetes had lower overall survival rates. Researchers conclude that managing both cancer and comorbidities is crucial for improving patient outcomes.
A recent study published in International Journal of Cancer found that boosting the production of a specific microRNA, miR-34a, increases sensitivity of bladder cancer cells to chemotherapy. The study suggests that miR-34a may be used as a predictor of response to chemotherapy and a target for new drugs.
Researchers have discovered that complex changes in TP53 occur earlier than previously thought, setting the stage for additional abnormalities. This finding could help scientists determine which mutations lead to precancerous lesions and invasive carcinomas.
Patients treated with sunitinib and sorafenib showed an antibody response comparable to healthy participants, indicating the flu vaccine is safe and effective. This finding has broad implications for patient management beyond targeted therapy.
A new study from UT MD Anderson Cancer Center found that nearly half of women with advanced breast cancer in the US are not receiving life-saving post-mastectomy radiation therapy (PMRT), despite evidence-based guidelines outlining its benefits. The study suggests that better strategies, such as requiring compliance for accreditation a...
A new study found that despite publication of treatment guidelines, only 55% of older high-risk breast cancer patients received recommended radiation treatment after mastectomy. The lack of improvement in radiation use suggests guidelines may not be effectively improving care for breast cancer patients.
A holistic approach to treating cancer pain that addresses psychological, social, and spiritual needs can enhance treatment outcomes and ease suffering. Research suggests integrating palliative care from diagnosis can improve quality of life, reduce depression, and increase survival time for lung cancer patients.
A study found that men diagnosed with prostate cancer who are also smokers have an increased risk of dying from prostate cancer, as well as all-cause and cardiovascular disease mortality. Smoking cessation after diagnosis did not significantly impact mortality risks compared to never-smokers.
The foundation awarded Clinical Investigator Awards to nine early-career physician-scientists conducting patient-oriented cancer research at major centers. The recipients will receive $450,000 each over three years, while Continuation Grants will provide an additional two years of funding totaling $300,000.
A study published in Archives of Surgery found that most hospitals follow established practice guidelines for surgical treatment of cancer patients with Medicare. However, disparities in care exist, with patients receiving the right care at the right time not always guaranteed.
A large study published in the Journal of the National Cancer Institute found that patients with Barrett's esophagus have a lower risk of esophageal cancer than previously thought. Men and individuals aged 60-69 were found to be at higher risk, highlighting the importance of personalized risk scores.
A low-carbohydrate, high-protein diet has been shown to slow the growth of tumors and reduce the risk of cancer in mice. The study found that restricting carbohydrate intake can limit blood glucose and insulin, promoting tumor growth. A low-carb diet also boosted the immune system's ability to kill cancer cells and prevented obesity.
The new iGXT Platform combines genetically engineered mouse models with patient-derived tumor xenograft models for more accurate cancer drug testing. The partnership aims to improve treatment outcomes by identifying effective biomarkers and personalized therapy options.
Researchers recommend a national strategy for therapeutic cancer vaccines, focusing on cancers with poor treatment options. Vaccines targeting such cancers may offer better survival rates and fewer side effects than current treatments.
Researchers are using genomic research to identify new genes that give rise to osteosarcoma and develop personalized blood tests to monitor disease in patients. The goal is to improve treatment of this difficult disease through better diagnosis and monitoring.
A new study by Nancy Keating found that VHA care is at least as good as, and in some cases better than, Medicare-funded private sector care for men 65 years and older. The VHA's coordinated care approach, salaried doctors, and lack of financial incentives for overuse may contribute to its high quality.
Researchers developed a new alpha-emitter-based therapy that effectively targets and cures neuroendocrine tumors without harming healthy tissues. The treatment, called 213Bi-DOTATOC peptide receptor alpha-therapy, showed promising results in patients with liver metastases resistant to beta-particle peptide therapy.
Researchers found that Tai Chi improves cognitive functioning and psychological health in women who have undergone chemotherapy. The study suggests that Tai Chi could be a valuable addition to cancer treatment for mitigating cognitive decline.
Researchers developed a novel form of radioimmunotherapy that targets antigens associated with renal cell carcinoma. Patients receiving up to three doses show dramatic slowing of cancer growth and stabilization of their disease. The therapy, Lu-177-cG250, targets kidney tumors with high effectiveness for reducing cancer proliferation.
A recent study by Fred Hutchinson Cancer Center found that bankruptcy rates among cancer patients rise fourfold within five years of diagnosis. The risk is highest for lung, thyroid and leukemia/lymphoma cancer patients, who face significant financial stress due to income loss and treatment costs.
A Mayo Clinic study has found that a mutant gene thought to accelerate tumor growth actually inhibits the spread of malignant cells, showing promise for novel cancer therapies. The PAX8/PPARγ fusion protein functions as a tumor suppressor by upregulating anti-tumor agents.
Research at the University of Texas MD Anderson Cancer Center found that customizing targeted therapies based on a patient's specific gene mutations can lead to higher response rates, survival, and failure-free survival compared to non-matched patients. This approach has shown promise in treating solid tumors with gene aberrations.
A clinical trial published in the New England Journal of Medicine reveals that a vaccine combined with Interleukin-2 improves response rate and progression-free survival for patients with advanced melanoma. The vaccine stimulates the immune system to recognize and attack tumor cells, resulting in increased survival rates.
Researchers are conducting a clinical trial called MANTICORE to detect and treat cardiovascular disease in breast cancer patients before treatment begins. The study aims to use special blood tests and imaging scans to identify potential cardiac risk factors.
Researchers have discovered that protein kinase C inhibitors can block kidney damage caused by the cancer drug cisplatin. This finding suggests using these inhibitors as an adjunct therapy to reduce toxicity and improve treatment outcomes.
Scientists have identified a drug combination that shows a survival advantage in advanced lung cancer patients who no longer respond to existing therapies. The combination of bexarotene and erlotinib broadens the reach to include patients resistant due to ras mutations, offering new hope for those with limited treatment options.
The study found that the vaccine improved response rates by 16% and progression-free survival by 2.2 months in patients compared to those without the vaccine. The researchers aim to broaden their approach using mixtures of peptides and other immune-stimulatory agents.
A study by University of Pennsylvania researchers found that even with private health insurance, newly diagnosed cancer patients often struggle to schedule an appointment with an oncologist. The authors suggest that patient navigator programs and staff training could help improve access to care.
A University of Michigan Health System study shows surgery mortality dropped substantially for eight different high-risk surgeries performed on 3.2 million Medicare patients from 1999 to 2008. High-volume hospitals and their expertise drove a significant decline in deaths, particularly in pancreatectomy and cystectomy.
The Society of Gynecologic Oncology has released guidelines for surveillance of gynecologic cancer recurrence in women who have had a complete response to primary cancer therapy. The recommendations focus on clinical effectiveness and cost-effectiveness, advising against routine cytologic procedures or imaging unless necessary.
A recent Korean survey found that most cancer patients, family members, oncologists, and the general public are receptive to ending futile life-sustaining treatments for terminally ill patients. This positive attitude towards withdrawing such treatments is attributed to patient autonomy and hastening the dying process.
A recent study published by the European Alliance of Associations for Rheumatology (EULAR) found that arthritis patients treated with anti-tumour necrosis factor agents do not have an overall increased cancer risk. The nine-year follow-up study showed no significant difference in cancer risk among patients with rheumatoid arthritis, ps...
A randomized, controlled trial found that patient navigators can significantly improve CRC screening rates among low-income, black, and non-English-speaking patients. The study suggests that focusing on these populations with patient navigation may be an effective approach to reducing screening disparities.
A phase II study by the University of Texas M. D. Anderson Cancer Center found that an antibody-guided chemotherapy drug eradicated or greatly reduced ALL cells in 61% of patients with resistant or recurrent disease. This makes it a potential most active single-agent therapy for ALL.
A recent study found that granting patients full access to their medical records increases their satisfaction without causing anxiety. The research, published in the Cancer journal, suggests that providing accurate information through medical records can complement verbal communication with physicians and improve patient outcomes.
A study led by the University of California, San Francisco found that childhood cancer survivors have a significantly higher risk of developing gastrointestinal complications later in life. Over 40% of cancer survivors reported experiencing some type of GI complication within 20 years after treatment.
A new study from MD Anderson Cancer Center found that yoga improved physical functioning, general health, and reduced cortisol levels in women with breast cancer. Yoga also helped patients find meaning in their cancer experience and report positive life changes after treatment.
A new treatment combination of a PARP inhibitor with chemotherapy offered significant benefit in patients with metastatic colon cancer who had exhausted all standard therapies. The study found that the treatment controlled cancer growth for nearly six months in 23% of patients, with two experiencing a partial response.
New studies released by ASCO highlight advances in cervical cancer screening, ovarian cancer detection, and prostate cancer risk prediction. The studies also explore genetic biomarkers for chemotherapy-induced neuropathy and potential treatments for relapsed ovarian cancer.
A blood test counting circulating tumor cells is a reliable indicator of disease progression in patients with metastatic breast cancer. The test's predictive value remains consistent regardless of treatment type or sites of disease involvement.
A new study links obstructive sleep apnea (OSA) to increased tumor growth and aggressiveness in melanoma cancer cells in mice. Recurrent hypoxia, a hallmark of OSA, enhances tumor proliferation and necrosis.
Researchers at VCU Massey Cancer Center have found a new biomarker related to the immune system that can predict breast cancer recurrence. The five-gene signature shows over 85% accuracy in predicting relapse-free survival.
A study published in the Journal of the National Cancer Institute found that patient reports of family cancer history are not highly accurate. The study revealed low to moderate accuracy rates for breast, colorectal, prostate, and lung cancer diagnoses, with higher accuracy rates for first-degree relatives
Researchers at Mayo Clinic have found a reliable method to detect pancreatic cancer through DNA testing of stool samples, with a marker detecting methylated genes in 70% of patients. This noninvasive test may lead to increased early detection and improved survival rates for those diagnosed with the disease.
Researchers identified previously undiscovered high-risk genetic features in T-cell acute lymphocytic leukemia (T-ALL) using zebrafish models. These genetic characteristics can predict which patients are more likely to experience aggressive forms of the disease that recur after treatment or do not respond to therapy.
A University of Alberta study found that submandibular gland transfer helps prevent radiation-induced dry mouth in cancer patients. The procedure improved speech but made swallowing more difficult, leading to nutritional issues and decreased quality of life.
Researchers at MD Anderson Cancer Center discovered WWP2's role in regulating PTEN, a tumor suppressor protein. WWP2 binding to PTEN leads to its degradation, allowing cancer cells to grow uncontrollably.
A study found that a pelvic MRI scan can identify local recurrence in prostate cancer patients with rising or persistently elevated PSA levels. About one-third of these patients have a low PSA level of less than 1, making it possible to treat them with higher doses and potentially increasing cure rates.
Pediatric cancer patients receive more accurate treatment delivery with proton radiography, reducing radiation exposure compared to standard diagnostic X-rays and cone beam CT. Proton imaging also enables real-time tumor tracking during treatment, benefiting children's sensitive growing bodies.
Low health literacy is a significant barrier to quality care for elderly cancer patients, but using simple and effective assessment tools can help. Nurses can assess patients' literacy levels and tailor communications to match their understanding, improving communication and health outcomes.
A team of surgeons from Mayo Clinic has found robotic surgery effective in treating larynx cancer, with patients able to resume normal eating and speaking after surgery. The study showed that robotic surgery was easier to perform than traditional approaches and resulted in clean, disease-free margins.
Researchers have developed a new technique that allows cancer-fighting cells to survive in patients' bloodstreams for over a year, without the need for toxic treatments. The study showed promising results, with one patient remaining cancer-free two years after treatment.
A new study found that Blacks are most willing to use up all personal financial resources to prolong life after lung or colorectal cancer diagnosis. Hispanic and Asian patients showed intermediate preferences. Factors influencing willingness include age, social support, and marital status.
A study found that black Americans are more willing to spend all their personal finances on cancer treatment to extend life, compared to whites. This discovery highlights the importance of understanding patients' financial decisions in delivering high-quality care.
Activation of CTNNB1 biomarker is associated with better survival rates among obese patients with colorectal cancer, while physical activity improves survival for those without CTNNB1 activation. The study suggests a possible interactive effect between tumor CTNNB1 signaling and energy balance status on tumor cell behavior.
Two studies published in JAMA describe the first clinical applications of whole-genome sequencing in patients with cancer, enabling targeted therapies based on genetic mutations. The technology is becoming increasingly affordable, with costs expected to drop below $10,000 within five years.
Two studies highlight the power of sequencing cancer patients' genomes, identifying novel genetic mutations that guide treatment. Researchers used genome sequencing to diagnose a patient with acute myeloid leukemia and breast cancer, changing her course from stem cell transplant to targeted chemotherapy.
A new study aims to improve the care of African Americans with cancer pain by providing a five-week program called Power Over Pain - Coaching or POP-C. The program addresses the challenges to pain care in this urban community and seeks to reduce suffering, distress, and burden among patients and caregivers.
A study found that late cancer diagnosis is a major factor in hospital cancer deaths in Northern Ireland, where over half of patients prefer to die at home. The study highlights the importance of early recognition of cancer symptoms and improving community services to support patients' wishes.
A Phase III study found that GOLFIG increased progression-free survival to 16.5 months, compared to 7.5 months with FOLFOX regimen. Researchers added gemcitabine and granulocyte-macrophage colony stimulating factor to boost immune system.